XML 61 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Liquidity and Capital Resources (Details)
1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Nov. 11, 2025
USD ($)
$ / shares
shares
Apr. 30, 2025
USD ($)
$ / shares
shares
Aug. 24, 2022
USD ($)
Feb. 28, 2025
USD ($)
Director
$ / shares
shares
Apr. 30, 2024
USD ($)
Feb. 28, 2025
USD ($)
$ / shares
shares
Mar. 30, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Nov. 12, 2025
$ / shares
Aug. 31, 2022
USD ($)
Liquidity [Abstract]                      
Cash and cash equivalents               $ 26,711,969 $ 41,689,591    
Registered securities in Shelf Registration Statement                     $ 150,000,000
Placement Shares available for sale                     $ 97,000,000
Proceeds from issuance of common stock               9,709,064 0    
Proceeds from sale of tax benefits         $ 900,000 $ 1,200,000          
Loan repayment               $ 19,000,000 $ 0    
Sales Agreement [Member]                      
Liquidity [Abstract]                      
Commission paid on Placement Shares sold                     3.00%
Issuance of common stock (in shares) | shares               0 3,428,681    
Proceeds from issuance of common stock               $ 0 $ 19,500,000    
Sales Agreement [Member] | Maximum [Member]                      
Liquidity [Abstract]                      
Placement Shares available for sale                     $ 50,000,000
New Sales Agreement [Member]                      
Liquidity [Abstract]                      
Issuance of common stock (in shares) | shares               3,510,732 1,108,105    
Proceeds from issuance of common stock               $ 4,300,000 $ 3,200,000    
New Sales Agreement [Member] | Subsequent Event [Member]                      
Liquidity [Abstract]                      
Issuance of common stock (in shares) | shares             937,420        
Proceeds from issuance of common stock             $ 850,000        
February 2025 Offering [Member]                      
Liquidity [Abstract]                      
Aggregate shares to be sold (in shares) | shares       6,396,787   6,396,787          
Combined purchase price per share and warrant (in dollars per share) | $ / shares       $ 1.5   $ 1.5          
Number of directors participating in securities offering | Director       2              
Gross proceeds from securities offering       $ 11,000,000              
Net proceeds from securities offering       $ 10,050,000.00              
February 2025 Offering [Member] | Directors [Member]                      
Liquidity [Abstract]                      
Aggregate number of shares purchased in securities offering (in shares) | shares       30,121              
Offering price per share (in dollars per share) | $ / shares       $ 1.66   $ 1.66          
February 2025 Offering [Member] | Pre-funded Warrants [Member]                      
Liquidity [Abstract]                      
Number of shares of common stock that can be called by warrants (in shares) | shares       933,334   933,334          
Offering price per share (in dollars per share) | $ / shares       $ 1.4999   $ 1.4999          
Exercise price of warrants (in dollars per share) | $ / shares       $ 0.00001   $ 0.00001          
February 2025 Offering [Member] | Pre-funded Warrants [Member] | Directors [Member]                      
Liquidity [Abstract]                      
Aggregate number of shares purchased in securities offering (in shares) | shares       1              
February 2025 Offering [Member] | Common Stock Warrants [Member]                      
Liquidity [Abstract]                      
Number of shares of common stock that can be called by warrants (in shares) | shares 5,948,334     7,330,121   7,330,121          
Exercise price of warrants (in dollars per share) | $ / shares $ 1.5     $ 1.5   $ 1.5       $ 1  
February 2025 Offering [Member] | Common Stock Warrants [Member] | Directors [Member]                      
Liquidity [Abstract]                      
Number of shares of common stock that can be called by warrants (in shares) | shares       30,121   30,121          
Exercise price of warrants (in dollars per share) | $ / shares       $ 1.53   $ 1.53          
Securities Purchase Agreement [Member]                      
Liquidity [Abstract]                      
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.52                  
Term of warrants               10 years      
Securities Purchase Agreement [Member] | Maximum [Member]                      
Liquidity [Abstract]                      
Number of shares of common stock that can be called by warrants (in shares) | shares   1,000,000                  
November 2025 Offering [Member]                      
Liquidity [Abstract]                      
Aggregate shares to be sold (in shares) | shares 5,741,000                    
Offering price per share (in dollars per share) | $ / shares $ 0.91                    
Gross proceeds from securities offering $ 5,300,000                    
Net proceeds from securities offering $ 4,800,000                    
November 2025 Offering [Member] | Pre-funded Warrants [Member]                      
Liquidity [Abstract]                      
Number of shares of common stock that can be called by warrants (in shares) | shares 59,000                    
Aggregate number of shares purchased in securities offering (in shares) | shares 1                    
Offering price per share (in dollars per share) | $ / shares $ 0.9099                    
Exercise price of warrants (in dollars per share) | $ / shares $ 0.0001                    
November 2025 Offering [Member] | Common Stock Warrants [Member]                      
Liquidity [Abstract]                      
Number of shares of common stock that can be called by warrants (in shares) | shares 5,800,000                    
Exercise price of warrants (in dollars per share) | $ / shares $ 1                    
Term of warrants               5 years      
Loan and Security Agreement [Member]                      
Liquidity [Abstract]                      
Proceeds from issuance of secured loans     $ 24,600,000                
Loan repayment   $ 19,000,000                  
Debentures [Member]                      
Liquidity [Abstract]                      
Face amount   22,200,000                  
Proceeds from issuance   $ 20,000,000                  
Loan repayment               $ 2,500,000      
Cash amount used to determine minimum cash balance               15,000,000      
Adjustment to outstanding principal amount of Debentures used to determine minimum cash balance               3,000,000      
Maximum redemption amount per calendar month               $ 500,000